Pfizer Inc. - Facts About Menopause

Journal articles on hormone replacement therapy (HRT) ghostwritten by medical writers employed by the pharmaceutical industry serially understated the treatment s risks and promoted unapproved uses, according to an analysis of industry documents.. Many thousands more papers remain sealed as part of ...

Most notably, Pfizer (PFE) has completed data collection for it's 2186-patient study of Pristiq for the treatment of vasomotor symptoms, more commonly known as hot flashes. Wyeth, now part of Pfizer, began Pristiq's large trial in July of 2007, when the FDA ...

An experimental drug from Pfizer could benefit certain women with osteoporosis, federal advisers said Monday, despite concerns of side effects.A Food and Drug Administration panel of experts voted 9-3 that the benefits of Fablyn could outweigh its risks, including blood clots and ...

Federal regulators say a drug from Pfizer and Ligand Pharmaceuticals effectively treats osteoporosis, though they are concerned about deaths, blood clots and other problems seen in company studies.The Food and Drug Administration noted Thursday that women treated with Pfizer's Fablyn were more ...

Topic: Pfizer Inc.

Questions over ghostwriting in drug industry

Investment Opportunities in Women's Health

Panel cites benefits of Pfizer osteoporosis drug

FDA wary of deaths with Pfizer osteoporosis drug

Photo Gallery

From Around the Web

Video Gallery

Follow this Topic with...